Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Disease
1.2.2. Product
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Neglected Tropical Disease Treatment Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis
Chapter 4. Neglected Tropical Disease Treatment Market: Disease Business Analysis
4.1. Disease Market Share, 2024 & 2033
4.2. Disease Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Disease, 2021 to 2033 (USD Million)
4.4. Dengue
4.4.1. Dengue Market, 2021-2033 (USD Million)
4.5. Rabies
4.5.1. Rabies Market, 2021-2033 (USD Million)
4.6. Trachoma
4.6.1. Trachoma Market, 2021-2033 (USD Million)
4.7. Buruli Ulcer
4.7.1. Buruli Ulcer Market, 2021-2033 (USD Million)
4.8. Yaws
4.8.1. Yaws Market, 2021-2033 (USD Million)
4.9. Leprosy
4.9.1. Leprosy Market, 2021-2033 (USD Million)
4.10. Chagas Disease
4.10.1. Chagas Disease Market, 2021-2033 (USD Million)
4.11. Human African Trypanosomiasis (Sleeping Sickness)
4.11.1. Human African Trypanosomiasis (Sleeping Sickness) Market, 2021-2033 (USD Million)
4.12. Leishmaniases
4.12.1. Leishmaniases Market, 2021-2033 (USD Million)
4.13. Soil-transmitted Helminthiases
4.13.1. Soil-transmitted Helminthiases Market, 2021-2033 (USD Million)
4.14. Others
4.14.1. Others Market, 2021-2033 (USD Million)
Chapter 5. Neglected Tropical Disease Treatment Market: Product Business Analysis
5.1. Product Market Share, 2024 & 2033
5.2. Product Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
5.4. Drugs
5.4.1. Drugs Market, 2021-2033 (USD Million)
5.4.2. Anti-Parasite
5.4.2.1. Anti-Parasite Market, 2021-2033 (USD Million)
5.4.3. Antifungal
5.4.3.1. Antifungal Market, 2021-2033 (USD Million)
5.4.4. Antibiotics
5.4.4.1. Antibiotics Market, 2021-2033 (USD Million)
5.4.5. Others
5.4.5.1. Others Market, 2021-2033 (USD Million)
5.5. Vaccines
5.5.1. Vaccines Market, 2021-2033 (USD Million)
Chapter 6. Neglected Tropical Disease Treatment Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2033
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
6.4. North America
6.4.1. North America Neglected Tropical Disease Treatment Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Target Disease Prevalence
6.4.2.3. Regulatory Framework
6.4.2.4. Reimbursement Framework
6.4.2.5. U.S. Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Regulatory Framework
6.4.3.4. Reimbursement Framework
6.4.3.5. U.S. Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Regulatory Framework
6.4.4.4. Reimbursement Framework
6.4.4.5. Mexico Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Europe
6.5.1. Europe Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Target Disease Prevalence
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement Framework
6.5.2.5. Uk Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement Framework
6.5.3.5. Germany Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Target Disease Prevalence
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement Framework
6.5.4.5. France Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Target Disease Prevalence
6.5.5.3. Regulatory Framework
6.5.5.4. Reimbursement Framework
6.5.5.5. Italy Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Target Disease Prevalence
6.5.6.3. Regulatory Framework
6.5.6.4. Reimbursement Framework
6.5.6.5. Spain Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.7. Denmark
6.5.7.1. Key Country Dynamics
6.5.7.2. Target Disease Prevalence
6.5.7.3. Regulatory Framework
6.5.7.4. Reimbursement Framework
6.5.7.5. Denmark Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.8. Sweden
6.5.8.1. Key Country Dynamics
6.5.8.2. Target Disease Prevalence
6.5.8.3. Regulatory Framework
6.5.8.4. Reimbursement Framework
6.5.8.5. Sweden Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.9. Norway
6.5.9.1. Key Country Dynamics
6.5.9.2. Target Disease Prevalence
6.5.9.3. Regulatory Framework
6.5.9.4. Reimbursement Framework
6.5.9.5. Norway Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Asia-Pacific
6.6.1. Asia-Pacific Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Target Disease Prevalence
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement Framework
6.6.2.5. Japan Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement Framework
6.6.3.5. China Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement Framework
6.6.4.5. India Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement Framework
6.6.5.5. Australia Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Target Disease Prevalence
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement Framework
6.6.6.5. South Korea Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Target Disease Prevalence
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement Framework
6.6.7.5. Thailand Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7. Latin America
6.7.1. Latin America Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Target Disease Prevalence
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement Framework
6.7.2.5. Japan Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Target Disease Prevalence
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement Framework
6.7.3.5. China Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8. Middle East and Africa
6.8.1. Middle East and Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Target Disease Prevalence
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement Framework
6.8.2.5. South Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Target Disease Prevalence
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement Framework
6.8.3.5. Saudi Arabia Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Target Disease Prevalence
6.8.4.3. Regulatory Framework
6.8.4.4. Reimbursement Framework
6.8.4.5. UAE Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Target Disease Prevalence
6.8.5.3. Regulatory Framework
6.8.5.4. Reimbursement Framework
6.8.5.5. Kuwait Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. F. Hoffmann-La Roche Ltd
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Disease Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Bayer AG
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Disease Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. GlaxoSmithKline plc
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Disease Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Novartis AG
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Disease Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Pfizer, Inc.
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Disease Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Eisai Co. Ltd.
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Disease Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Sanofi
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Disease Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Astellas Pharma
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Disease Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Takeda Pharmaceutical Company Limited
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Disease Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. Gilead Sciences.
7.5.10.1. Overview
7.5.10.2. Financial Performance
7.5.10.3. Disease Benchmarking
7.5.10.4. Strategic Initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global neglected tropical disease treatment market, by region, 2021-2033 (USD Million)
Table 4. Global neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 5. Global neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 6. North America neglected tropical disease treatment market, by country, 2021-2033 (USD Million)
Table 7. North America neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 8. North America neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 9. U.S. neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 10. U.S. neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 11. Canada neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 12. Canada neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 13. Mexico neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 14. Mexico neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 15. Europe neglected tropical disease treatment market, by country, 2021-2033 (USD Million)
Table 16. Europe neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 17. Europe neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 18. UK neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 19. UK neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 20. Germany neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 21. Germany neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 22. France neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 23. France neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 24. Italy neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 25. Italy neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 26. Spain neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 27. Spain neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 28. Norway neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 29. Norway neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 30. Denmark neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 31. Denmark neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 32. Sweden neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 33. Sweden neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 34. Asia-Pacific neglected tropical disease treatment market, by country, 2021-2033 (USD Million)
Table 35. Asia-Pacific neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 36. Asia-Pacific neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 37. Japan neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 38. Japan neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 39. China neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 40. China neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 41. India neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 42. India neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 43. Australia neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 44. Australia neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 45. South Korea neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 46. South Korea neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 47. Thailand neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 48. Thailand neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 49. Latin America neglected tropical disease treatment market, by country, 2021-2033 (USD Million)
Table 50. Latin America neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 51. Latin America neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 52. Brazil neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 53. Brazil neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 54. Argentina neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 55. Argentina neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 56. Middle East & Africa Neglected tropical disease treatment market, by country, 2021-2033 (USD Million)
Table 57. Middle East & Africa neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 58. Middle East & Africa neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 59. South Africa neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 60. South Africa neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 61. Saudi Arabia neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 62. Saudi Arabia neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 63. UAE neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 64. UAE neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
Table 65. Kuwait neglected tropical disease treatment market, by disease, 2021-2033 (USD Million)
Table 66. Kuwait neglected tropical disease treatment market, by product, 2021-2033 (USD Million)
List of Figures
Figure 1 Neglected tropical disease treatment market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Therapeutic approach and disease outlook (USD Million)
Figure 10 Competitive landscape
Figure 11 Neglected tropical disease treatment market dynamics
Figure 12 Neglected tropical disease treatment market: Porter’s five forces analysis
Figure 13 Neglected tropical disease treatment market: PESTLE analysis
Figure 14 Dengue market, 2021-2033 (USD Million)
Figure 15 Rabies market, 2021-2033 (USD Million)
Figure 16 Trachoma market, 2021-2033 (USD Million)
Figure 17 Buruli ulcer market, 2021-2033 (USD Million)
Figure 18 Yaws market, 2021-2033 (USD Million)
Figure 19 Leprosy market, 2021-2033 (USD Million)
Figure 20 Human african trypanosomiasis (sleeping sickness) market, 2021-2033 (USD Million)
Figure 21 Leishmaniases market, 2021-2033 (USD Million)
Figure 22 Soil-transmitted helminthiases market, 2021-2033 (USD Million)
Figure 23 Others market, 2021-2033 (USD Million)
Figure 24 Product market, 2021-2033 (USD Million)
Figure 25 Drugs market, 2021-2033 (USD Million)
Figure 26 Anti-Parasite market, 2021-2033 (USD Million)
Figure 27 Antifungal market, 2021-2033 (USD Million)
Figure 28 Antibiotics market, 2021-2033 (USD Million)
Figure 29 Others market, 2021-2033 (USD Million)
Figure 30 Vaccines market, 2021-2033 (USD Million)
Figure 31 Neglected tropical disease treatment market revenue, by region
Figure 32 Regional marketplace: Key takeaways
Figure 33 North America neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 34 U.S. country dynamics
Figure 35 U.S. neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 36 Canada country dynamics
Figure 37 Canada neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 38 Mexico country dynamics
Figure 39 Mexico neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 40 Europe neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 41 UK country dynamics
Figure 42 UK neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 43 Germany country dynamics
Figure 44 Germany neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 45 France country dynamics
Figure 46 France neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 47 Italy country dynamics
Figure 48 Italy neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 49 Spain country dynamics
Figure 50 Spain neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 51 Norway country dynamics
Figure 52 Norway neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 53 Sweden country dynamics
Figure 54 Sweden neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 55 Denmark country dynamics
Figure 56 Denmark neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 57 Asia-Pacific neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 58 Japan country dynamics
Figure 59 Japan neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 60 China country dynamics
Figure 61 China neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 62 India country dynamics
Figure 63 India neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 64 Australia country dynamics
Figure 65 Australia neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 66 South Korea country dynamics
Figure 67 South Korea neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 68 Thailand country dynamics
Figure 69 Thailand neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 70 Latin America neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 71 Brazil country dynamics
Figure 72 Brazil neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 73 Argentina country dynamics
Figure 74 Argentina neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 75 MEA neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 76 South Africa country dynamics
Figure 77 South Africa neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 78 Saudi Arabia country dynamics
Figure 79 Saudi Arabia neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 80 UAE country dynamics
Figure 81 UAE neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 82 Kuwait country dynamics
Figure 83 Kuwait neglected tropical disease treatment market, 2021-2033 (USD Million)
Figure 84 Company categorization
Figure 85 Company market position analysis
Figure 86 Strategic framework
